Positions

Investigator On

  • Smad8 is a Driver of Duchenne Muscular Dystrophy Pathology Via MyomiR Repression  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2020 - 2025
  • Smad8 in Dystrophic Muscle Disease & Its Role in MicroRNA Regulation & Disease Progression  awarded by KAUL PEDIATRIC RESEARCH INSTITUTE 2019 - 2021
  • MiR-486 is an Epigenetic Regulator of the Duchenne Muscular Dystrophy  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2020 - 2021
  • Effects of Myristoylated Alanine-Rich C-Kinase Substrate on Microglial Activation  awarded by American Brain Tumor Association 2020
  • Centers of Research Translation (CoRT)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2017
  • Centers of Research Translation (CoRT) - Project 3  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2017
  • UAB Research and Education Program in Neurology, Neurosurgery, and Neuropathology  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2012 - 2017
  • The Role of the Terminal Complement Pathway in ALS  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2013 - 2016
  • Negative Impact of RNA Destabilizer Tristetraprolin on Glioma Growth  awarded by National Cancer Institute/NIH/DHHS 2009 - 2014
  • Dysregulation of VEGF RNA Stability in Amyotrophic Lateral Sclerosis  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2008 - 2014
  • Education And Training

  • UAB Hospital, Postdoctoral Fellowship
  • Doctor of Medicine, Duke University 1985
  • University Hospitals Case Medical Center, Internship 1986
  • Duke University Medical Center, Residency 1989
  • University Hospitals Case Medical Center, Residency 1987
  • Cleveland Clinic Foundation, Postdoctoral Fellowship 1992
  • Duke University Medical Center, Postdoctoral Fellowship 1991
  • Full Name

  • Peter King